Viewing Study NCT02731560


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-01-07 @ 5:48 PM
Study NCT ID: NCT02731560
Status: COMPLETED
Last Update Posted: 2016-04-07
First Post: 2016-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)
Sponsor: Prof. Abid Z. Farooqi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module